版權(quán)說明：本文檔由用戶提供并上傳，收益歸屬內(nèi)容提供方，若內(nèi)容存在侵權(quán)，請進行舉報或認領(lǐng)
文檔簡介
ModernManagementofProlongedRuptureofMembranesJosephR.BiggioJr.,M.D.DepartmentofObstetrics&GynecologyDivisionofMaternal-FetalMedicineUniversityofAlabamaatBirminghamModernManagementofProlongedPROMAmniorrhexispriortoonsetofactivelaborregardlessofgestationalagePrematureRuptureofMembranesPROMAmniorrhexispriortoonsePPROMAmniorrhexis<37weeks’gestationalagepriortoonsetofactivelaborPretermPrematureRuptureofMembranesPPROMAmniorrhexis<37weeks’LatencyIntervalfromRuptureofMembranestoOnsetofActiveLaborLatencyIntervalfromRuptureoDiagnosisHistoryAvoiddigitalexamVaginalPoolNitrazinePaperFerningUltrasoundAmniocentesis/DyeStudyDiagnosisHistoryPROMnearTermManagementgestationalagedependentInductionvs.awaitingspontaneouslaborAntibioticprophylaxisperACOG/CDCrecommendationsPROMnearTermManagementgestaInductionvs.ExpectantManagement>5,000womenrandomizedOxytocin,PGE2orexpectantmanagementupto4daysNodifferenceincesareansectionorneonatalinfectionLesschorioamnionitisininductionwithoxytocingroupHannah,NEJM,1996Inductionvs.ExpectantManageEpidemiologyofPretermBirthPPROMSpontaneousPretermDelivery IndicatedPretermDelivery 28%46%26%Andrews,1995EpidemiologyofPretermBirthPPPROM
RiskFactorsLower/UpperGenitalTractInfectionProteasesProstaglandinsHistoryofPPROMIncompetentCervixAbruptionPolyhydramniosMultipleGestationSmokingPPROM
RiskFactorsLower/UpperPPROM
ComplicationsMaternal/FetalInfectionPrematureLaborandDeliveryUmbilicalCordProlapseFetalHypoxia2oCordCompressionIncreasedRateofCesareanSectionIntrauterineGrowthRestrictionAbruptionStillbirthPPROM
ComplicationsMaternal/FePPROM
StandardManagementConfirmationofDiagnosisVerificationofGestationalAgeR/OLabor/Infection/FetalCompromiseAvoidDigitalVaginalExaminationsInHospitalObservationBedrestPPROM
StandardManagementConfiPPROM
Latency
GestationalAge(Weeks)%PatientswithLatency>1Week2550750Wilson,Obstetrics&Gynecology,1982PPROM
LatencyGestationalAgePPROM
VaginalExaminationGestationalAge(Weeks)2015105LatencyDaysNoExamExamLewis,Obstetrics&Gynecology,1992PPROM
VaginalExaminationGestaPreviablePPROM<24weeksPoorprognosisforsuccessfuloutcomeOutcomemaybedifferentforspontaneousvs.iatrogenicPreviablePPROM<24weeksPreviablePPROM
Complications
UterineInfectionPulmonaryHypoplasiaLimbCompressionDeformitiesIntrauterineGrowthRestrictionPreviablePPROM
ComplicationsPreviablePPROM
OutcomesPreviablePPROM
OutcomesPPROM
ManagementIssues
TimingofDeliveryTocolysisAntibioticsSteroidsAmniocentesisObservationvs.InductionFetalLungMaturityTestingFetalSurveillancePPROM
ManagementIssuesTimingTimingofDeliveryTimingofDeliveryNeonatalMorbidity/Mortality
UAB(1995-1996)%NeonatalMorbidity/Mortality
URNICUSurvivalandMorbidityData(1995-1996)%NeonatesRNICUSurvivalandMorbidityDTocolysisTocolysisPPROM
TocolysisWeiner,AJOG,1988PPROM
TocolysisWeiner,AJOG,1PPROM
TocolysisGarite,AJOG,1987PPROM
TocolysisGarite,AJOG,1AntibioticsAntibioticsPretermLabor
ChorioamnionColonization0￡30weeks31-34weeks34-36weeks337weeks255075%PatientsColonizedSpontaneousPretermLaborIndicatedCassell,1993PretermLabor
ChorioamnionColPPROM
AntibioticTherapyReductionMaternal/PerinatalInfectionProlongLatencyPeriodImproveNeonatalOutcomePPROM
AntibioticTherapyReductAntibiotic:PPROM
NIH-MFMNetworkStudyPPROMbetween24and32weeksIVampicillinanderythromycinfor48hOralamoxicillin/erythromycinfor5daysIdentificationandRxofGBScarriersTocolysisandcorticosteroidsprohibited
Mercer,JAMA,1997Antibiotic:PPROM
NIH-MFMNetwAntibiotic:
NIH-MFMNetworkStudyNeonatalMorbidity***Antibiotic:
NIH-MFMNetworkAntibiotic:LatencyPeriod
NIH-MFMNetworkStudyAntibiotic:LatencyPeriod
NIHPPROM
AntibioticTherapyOptimalAntibioticRegimenRoute/DurationofAdministrationPPROM
AntibioticTherapyOptimaAntibiotics&PPROM:SummaryReductioninmaternalinfectiousmorbidityReductioninbirths<48hand<7dReductioninneonatalinfectiousmorbidityReductioninneonatesrequiringNICUandventilation>28dKenyon,CochraneLibrary,1999Antibiotics&PPROM:SummaryReAntibiotics&PPROM:SummaryNoclearreductioninperinataldeathNoclearreductionincerebralabnormalitiesKenyon,CochraneLibrary,1999Antibiotics&PPROM:SummaryNoAmniocentesisAmniocentesisPPROM
AmnioticFluidCultureGroupBStreptococcus 20%Gardnerellavaginalis 17%Peptostreptococcus 11%Fusobacteria 10%Bacteroidesfragilis 9%OtherStreptococci 9%Bacteroidessp. 5% PPROM
AmnioticFluidCultureGUtilityofAmniocentesisConfirm/RefutediagnosisofchorioamnionitisGlucose<15mg/dLCultureGramstainLungmaturitytestingUtilityofAmniocentesisConfirCorticosteroidsCorticosteroidsCorticosteroidsforFLMBetamethasoneDexamethasoneCorticosteroidsforFLMBetametPPROM
CorticosteroidsBlockTaeuschPapageorgiouYoungGariteCollaborativeIamsNelsonSimpsonMorales4317173880153382211212126241937801353546105124AuthorSteroidsControlEffectonRDSNumberofPatientsPPROM
CorticosteroidsBlock4326PPROM
CorticosteroidsCrowley,Ob/GynClinics,1992*PPROM
CorticosteroidsCrowley,PPROM
Corticosteroids+Antibiotics*Lewis,Obstetrics&Gynecology,1996PPROM
Corticosteroids+Antibi1994NIHConsensusConference:
CorticosteroidsinPPROMCorticosteroidsreduceincidence/severityofRDS,IVHBenefitsinPPROMupto30-32weeksNosignificantadverseoutcomesforcorticosteroiduseinPPROMImpactlessthanwithintactmembranes1994NIHConsensusConference:Observationvs.InductionObservationvs.InductionNeonatalMorbidity/Mortality
UAB(1995-1996)%NeonatalMorbidity/Mortality
UPPROM
Observationvs.InductionMercer,AJOG,1993**PPROM
Observationvs.InductioPPROM
ObservationvsInductionCox,Obstetrics&Gynecology,1995PPROM
ObservationvsInductionFetalLungMaturityTestingFetalLungMaturityTestingFetalLungMaturation
BiologicMarkers8642004268202428323640GestationalAge(weeks)L:SRatio%PhospholipidL:SPIPG10FetalLungMaturation
BiologicFetalLungMaturityEvaluationinVaginalPoolSpecimenL:SRatio NotReliableTDX:FLMAssay NotValidatedPG Useful
FetalLungMaturityEvaluationFetalSurveillanceFetalSurveillancePPROM
FetalSurveillanceDailyNon-StressTest(NST)VariablesTachycardiaLossofreactivityBiophysicalProfile(BPP)ContractionStressTest(CST)PPROM
FetalSurveillanceDailySummarySummaryUABManagementofPPROMPPROM34weeksDeliverPreviablePROMOutpatientobservationAntibioticprophylaxisOptionoftermination<22wkAdmissionatviability
UABManagementofPPROMPPROMPPROM23weeks,<34weeksAntibioticprophylaxis:Amoxicillin500tidx10d,Azithromycin1gmd1&d51courseBetamethasoneif<32weeksTestforpoolPGweeklybeginningat32weeksDeliverat34-35weeksUABManagementofPPROMPPROM23weeks,<34weeksUABModernManagementofProlongedRuptureofMembranesJosephR.BiggioJr.,M.D.DepartmentofObstetrics&GynecologyDivisionofMaternal-FetalMedicineUniversityofAlabamaatBirminghamModernManagementofProlongedPROMAmniorrhexispriortoonsetofactivelaborregardlessofgestationalagePrematureRuptureofMembranesPROMAmniorrhexispriortoonsePPROMAmniorrhexis<37weeks’gestationalagepriortoonsetofactivelaborPretermPrematureRuptureofMembranesPPROMAmniorrhexis<37weeks’LatencyIntervalfromRuptureofMembranestoOnsetofActiveLaborLatencyIntervalfromRuptureoDiagnosisHistoryAvoiddigitalexamVaginalPoolNitrazinePaperFerningUltrasoundAmniocentesis/DyeStudyDiagnosisHistoryPROMnearTermManagementgestationalagedependentInductionvs.awaitingspontaneouslaborAntibioticprophylaxisperACOG/CDCrecommendationsPROMnearTermManagementgestaInductionvs.ExpectantManagement>5,000womenrandomizedOxytocin,PGE2orexpectantmanagementupto4daysNodifferenceincesareansectionorneonatalinfectionLesschorioamnionitisininductionwithoxytocingroupHannah,NEJM,1996Inductionvs.ExpectantManageEpidemiologyofPretermBirthPPROMSpontaneousPretermDelivery IndicatedPretermDelivery 28%46%26%Andrews,1995EpidemiologyofPretermBirthPPPROM
RiskFactorsLower/UpperGenitalTractInfectionProteasesProstaglandinsHistoryofPPROMIncompetentCervixAbruptionPolyhydramniosMultipleGestationSmokingPPROM
RiskFactorsLower/UpperPPROM
ComplicationsMaternal/FetalInfectionPrematureLaborandDeliveryUmbilicalCordProlapseFetalHypoxia2oCordCompressionIncreasedRateofCesareanSectionIntrauterineGrowthRestrictionAbruptionStillbirthPPROM
ComplicationsMaternal/FePPROM
StandardManagementConfirmationofDiagnosisVerificationofGestationalAgeR/OLabor/Infection/FetalCompromiseAvoidDigitalVaginalExaminationsInHospitalObservationBedrestPPROM
StandardManagementConfiPPROM
Latency
GestationalAge(Weeks)%PatientswithLatency>1Week2550750Wilson,Obstetrics&Gynecology,1982PPROM
LatencyGestationalAgePPROM
VaginalExaminationGestationalAge(Weeks)2015105LatencyDaysNoExamExamLewis,Obstetrics&Gynecology,1992PPROM
VaginalExaminationGestaPreviablePPROM<24weeksPoorprognosisforsuccessfuloutcomeOutcomemaybedifferentforspontaneousvs.iatrogenicPreviablePPROM<24weeksPreviablePPROM
Complications
UterineInfectionPulmonaryHypoplasiaLimbCompressionDeformitiesIntrauterineGrowthRestrictionPreviablePPROM
ComplicationsPreviablePPROM
OutcomesPreviablePPROM
OutcomesPPROM
ManagementIssues
TimingofDeliveryTocolysisAntibioticsSteroidsAmniocentesisObservationvs.InductionFetalLungMaturityTestingFetalSurveillancePPROM
ManagementIssuesTimingTimingofDeliveryTimingofDeliveryNeonatalMorbidity/Mortality
UAB(1995-1996)%NeonatalMorbidity/Mortality
URNICUSurvivalandMorbidityData(1995-1996)%NeonatesRNICUSurvivalandMorbidityDTocolysisTocolysisPPROM
TocolysisWeiner,AJOG,1988PPROM
TocolysisWeiner,AJOG,1PPROM
TocolysisGarite,AJOG,1987PPROM
TocolysisGarite,AJOG,1AntibioticsAntibioticsPretermLabor
ChorioamnionColonization0￡30weeks31-34weeks34-36weeks337weeks255075%PatientsColonizedSpontaneousPretermLaborIndicatedCassell,1993PretermLabor
ChorioamnionColPPROM
AntibioticTherapyReductionMaternal/PerinatalInfectionProlongLatencyPeriodImproveNeonatalOutcomePPROM
AntibioticTherapyReductAntibiotic:PPROM
NIH-MFMNetworkStudyPPROMbetween24and32weeksIVampicillinanderythromycinfor48hOralamoxicillin/erythromycinfor5daysIdentificationandRxofGBScarriersTocolysisandcorticosteroidsprohibited
Mercer,JAMA,1997Antibiotic:PPROM
NIH-MFMNetwAntibiotic:
NIH-MFMNetworkStudyNeonatalMorbidity***Antibiotic:
NIH-MFMNetworkAntibiotic:LatencyPeriod
NIH-MFMNetworkStudyAntibiotic:LatencyPeriod
NIHPPROM
AntibioticTherapyOptimalAntibioticRegimenRoute/DurationofAdministrationPPROM
AntibioticTherapyOptimaAntibiotics&PPROM:SummaryReductioninmaternalinfectiousmorbidityReductioninbirths<48hand<7dReductioninneonatalinfectiousmorbidityReductioninneonatesrequiringNICUandventilation>28dKenyon,CochraneLibrary,1999Antibiotics&PPROM:SummaryReAntibiotics&PPROM:SummaryNoclearreductioninperinataldeathNoclearreductionincerebralabnormalitiesKenyon,CochraneLibrary,1999Antibiotics&PPROM:SummaryNoAmniocentesisAmniocentesisPPROM
AmnioticFluidCultureGroupBStreptococcus 20%Gardnerellavaginalis 17%Peptostreptococcus 11%Fusobacteria 10%Bacteroidesfragilis 9%OtherStreptococci 9%Bacteroidessp. 5% PPROM
AmnioticFluidCultureGUtilityofAmniocentesisConfirm/RefutediagnosisofchorioamnionitisGlucose<15mg/dLCultureGramstainLungmaturitytestingUtilityofAmniocentesisConfirCorticosteroidsCorticosteroidsCorticosteroidsforFLMBetamethasoneDexamethasoneCorticosteroidsforFLMBetametPPROM
CorticosteroidsBlockTaeuschPapageorgiouYoungGariteCollaborativeIamsNelsonSimpsonMorales4317173880153382211212126241937801353546105124AuthorSteroidsControlEffectonRDSNumberofPatientsPPROM
CorticosteroidsBlock4326PPROM
CorticosteroidsCrowley,Ob/GynClinics,1992*PPROM
CorticosteroidsCrowley,PPROM
Corticosteroids+Antibiotics*Lewis,Obstetrics&Gynecology,1996PPROM
Corticosteroids+Antibi1994NIHConsensusConference:
CorticosteroidsinPPROMCorticosteroidsreduceincidence/severityofRDS,IVHBenefitsinPPROMupto30-32weeksNosignificantadverseoutcomesforcorticosteroidusein
溫馨提示
- 1. 本站所有資源如無特殊說明，都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等，如果需要附件，請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙，網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽，若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間，僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理，對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯，并不能對任何下載內(nèi)容負責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容，請與我們聯(lián)系，我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025至2030年中國手工帽行業(yè)發(fā)展研究報告
- 2025至2030年中國平開雙節(jié)柜數(shù)據(jù)監(jiān)測研究報告
- 2025至2030年中國工裝襯衣行業(yè)發(fā)展研究報告001
- 2025至2030年中國工控機箱轉(zhuǎn)接卡市場分析及競爭策略研究報告001
- 2025至2030年中國工業(yè)烤爐行業(yè)投資前景及策略咨詢報告
- 肺結(jié)核的教育
- 高一上期末生物試卷及答案
- 高一地理試卷答案及解析
- 住房公積金AI應(yīng)用行業(yè)跨境出海戰(zhàn)略研究報告
- 數(shù)字銀行用戶體驗企業(yè)制定與實施新質(zhì)生產(chǎn)力戰(zhàn)略研究報告
- 員工反恐怖協(xié)議
- 2025年高考政治一輪復(fù)習(xí)知識清單必修四《哲學(xué)與文化》重難點知識
- 2021年4月17日江蘇事業(yè)單位考試《綜合知識和能力素質(zhì)》（管理崗客觀題）
- 《臨床技術(shù)操作規(guī)范-放射醫(yī)學(xué)檢查技術(shù)分冊》
- 生活中的魔法數(shù)學(xué)名師公開課獲獎?wù)n件百校聯(lián)賽一等獎?wù)n件
- 2024年同等學(xué)力申碩英語考試真題
- 江蘇省南京市六校2024-2025學(xué)年高一上學(xué)期期中聯(lián)合調(diào)研 化學(xué)試題
- 兒科基礎(chǔ)臨床知識題庫單選題100道及答案解析
- 消除“艾梅乙”醫(yī)療歧視-從我做起
- 臨床醫(yī)學(xué)檢驗試題及答案
- 2024塔式太陽能熱發(fā)電站熔融鹽儲熱系統(tǒng)安裝規(guī)范
評論
0/150
提交評論